Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT00513747 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

84

Enrollment

OTHER

Sponsor class

Stopped Insufficient accrual

Conditions

Leukemia

Interventions

BIOLOGICAL: rituximab
DRUG: fludarabine phosphate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]